Therefore, our data provided evidence that miR-550a-3-5p acts as a tumor suppressor via YAP inhibition in multiple cancer cells and a novel therapeutic tool for BRAF inhibitor resistance in BRAF-mutant colon and melanoma cells. The gene discussed is YAP1; the disease is neoplasm.